GB8919131D0 — Inhaler
Assigned to Riker Laboratories Inc · Expires 1989-10-04 · 37y expired
What this patent protects
An inhalation device comprising: (i) a breath-actuated inhaler comprising a medicament reservoir (6) mounted within a housing (2) which comprises a mouthpiece (4) and breath-actuation means which prevents dispensing from the reservoir until a patient inhales through the mouthpi…
USPTO Abstract
An inhalation device comprising: (i) a breath-actuated inhaler comprising a medicament reservoir (6) mounted within a housing (2) which comprises a mouthpiece (4) and breath-actuation means which prevents dispensing from the reservoir until a patient inhales through the mouthpiece, and (ii) a protective casing (34) surrounding the breath actuated inhaler, the casing comprising a body portion (36) and a movable cover (38) which may be displaced to allow a patient access to the mouthpiece (4) to use the breath-actuated inhaler whilst it is within the casing, the breath-actuated inhaler being removable from the protective casing and operable outside the casing. h
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.